Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

NCT06072001 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

558

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Pain Syndrome
Pain, Chronic
Chronic Pain
Chronic Pain Syndrome
Neuropathic Pain
Central Neuropathic Pain
Paraplegia
Multiple Sclerosis
Stroke
Phantom Limb Syndrome With Pain
Phantom Pain
Traumatic Brain Injury

Interventions

DRUG: Adezunap (AP707)
DRUG: Placebo

Sponsor

Apurano Pharmaceuticals GmbH